Troy A. Ignelzi, Chief Financial Officer at Karuna Therapeutics, Inc. (KRTX), sold 8,000 shares at $90.00 ($738K) on 2020-06-15, disclosed to the SEC on 2020-06-17.
Open-market sale of $738k KRTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.62 | 4,000 | $358K | 48.5% |
| 2 | $90.00 | 2,000 | $180K | 24.4% |
| 3 | $100.00 | 2,000 | $200K | 27.1% |
| Total | $92.31 avg | 8,000 | $738K | 100% |
| Filing → |
| KRTX | SELL | 2023-05-25 | $4.0M | — | Filing → |
| KRTX | SELL | 2023-02-23 | $1.1M | — | Filing → |
| KRTX | SELL | 2023-01-19 | $369K | — | Filing → |